FI914405A - Isoprenoidfosfolipas-a2-inhibitorer och dessa innehaollande preparat. - Google Patents

Isoprenoidfosfolipas-a2-inhibitorer och dessa innehaollande preparat. Download PDF

Info

Publication number
FI914405A
FI914405A FI914405A FI914405A FI914405A FI 914405 A FI914405 A FI 914405A FI 914405 A FI914405 A FI 914405A FI 914405 A FI914405 A FI 914405A FI 914405 A FI914405 A FI 914405A
Authority
FI
Finland
Prior art keywords
isoprenoidphospholipas
inhibitorer
preparat
dessa innehaollande
och dessa
Prior art date
Application number
FI914405A
Other languages
English (en)
Other versions
FI104168B1 (fi
FI914405A0 (fi
FI104168B (fi
Inventor
F Ivy Carroll
Anita Lewin
Kenneth Tramposch
Stephen A Steiner
Original Assignee
Bristol Myers Squipp Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squipp Company filed Critical Bristol Myers Squipp Company
Publication of FI914405A0 publication Critical patent/FI914405A0/fi
Publication of FI914405A publication Critical patent/FI914405A/fi
Application granted granted Critical
Publication of FI104168B1 publication Critical patent/FI104168B1/fi
Publication of FI104168B publication Critical patent/FI104168B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/64—Monocyclic acids with unsaturation outside the aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/20—Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by carboxyl groups or halides, anhydrides, or (thio)esters thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09—Geometrical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI914405A 1990-09-21 1991-09-19 Menetelmä terapeuttisesti käyttökelpoisten retinoidiyhdisteiden valmistamiseksi FI104168B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/586,159 US5141959A (en) 1990-09-21 1990-09-21 Isoprenoid phospholipase a2 inhibitors and preparations comprising same
US58615990 1990-09-21

Publications (4)

Publication Number Publication Date
FI914405A0 FI914405A0 (fi) 1991-09-19
FI914405A true FI914405A (fi) 1992-03-22
FI104168B1 FI104168B1 (fi) 1999-11-30
FI104168B FI104168B (fi) 1999-11-30

Family

ID=24344545

Family Applications (1)

Application Number Title Priority Date Filing Date
FI914405A FI104168B (fi) 1990-09-21 1991-09-19 Menetelmä terapeuttisesti käyttökelpoisten retinoidiyhdisteiden valmistamiseksi

Country Status (18)

Country Link
US (1) US5141959A (fi)
EP (1) EP0476682B1 (fi)
JP (1) JP2943089B2 (fi)
AT (1) ATE117979T1 (fi)
AU (1) AU637756B2 (fi)
CA (1) CA2051766A1 (fi)
DE (1) DE69107153T2 (fi)
DK (1) DK0476682T3 (fi)
ES (1) ES2067822T3 (fi)
FI (1) FI104168B (fi)
GR (1) GR3014944T3 (fi)
IE (1) IE66745B1 (fi)
IL (1) IL99536A (fi)
MX (1) MX9101163A (fi)
NZ (1) NZ239844A (fi)
OA (1) OA09514A (fi)
PT (1) PT99014B (fi)
ZA (1) ZA917531B (fi)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7189737B2 (en) * 1991-08-09 2007-03-13 Research Triangle Institute Cocaine receptor binding ligands
US5688781A (en) 1994-08-19 1997-11-18 Bristol-Myers Squibb Company Method for treating vascular leak syndrome
FR2735371B1 (fr) * 1995-06-19 1997-07-18 Cird Galderma Procede pour identifier des composes antagonistes des recepteurs rars
US6900228B1 (en) 1998-03-10 2005-05-31 Research Triangle Institute Opiate compounds, methods of making and methods of use
US6267945B1 (en) * 1998-12-18 2001-07-31 Neuromed Technologies, Inc. Farnesol-related calcium channel blockers
US6538010B1 (en) * 2000-11-08 2003-03-25 Research Triangle Institute Compounds and methods for promoting smoking cessation
US8026280B2 (en) 2001-03-27 2011-09-27 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US6495719B2 (en) 2001-03-27 2002-12-17 Circagen Pharmaceutical Histone deacetylase inhibitors
US7312247B2 (en) 2001-03-27 2007-12-25 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7842727B2 (en) * 2001-03-27 2010-11-30 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
AU2003243272A1 (en) * 2002-05-22 2003-12-12 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors based on alpha-ketoepoxide compounds
AU2003237397A1 (en) * 2002-06-04 2003-12-19 Sequenom, Inc. Diagnosing predisposition to fat deposition and therapeutic methods for reducing fat deposition and treatment of associated conditions
JP2006508642A (ja) * 2002-06-27 2006-03-16 ハークネス ファーマシューティカルズ，インコーポレイティド 脂肪の蓄積を減少させる方法と、関連疾患を治療するための方法
US20050239077A1 (en) * 2002-06-27 2005-10-27 Adam Gail I R Diagnosing predisposition to fat deposition and associated conditions
AU2003291097A1 (en) * 2002-11-20 2004-06-15 Errant Gene Therapeutics, Llc Treatment of lung cells with histone deacetylase inhibitors
CA2587013A1 (en) * 2004-11-08 2006-05-18 Errant Gene Therapeutics, Llc Histone deacetylase inhibitors
US7872023B2 (en) * 2005-02-17 2011-01-18 Research Triangle Institute Kappa opioid receptor ligands
US7399762B2 (en) * 2005-04-25 2008-07-15 Research Triangle Institute Opioid receptor agonist compounds and their use in treatment of pain
US7476679B2 (en) * 2005-07-26 2009-01-13 Research Triangle Institute Octahydroisoquinoline compounds as opioid receptor modulators
MX2009011360A (es) * 2007-04-20 2010-02-12 Acucela Inc Compuestos derivados de estirenilo para tratar enfermedades y trastornos oftalmicos.
US8048895B2 (en) * 2008-04-18 2011-11-01 Research Triangle Institute Kappa opioid receptor ligands
EP2539706B1 (en) 2010-02-24 2015-03-04 Research Triangle Institute Arylpiperazine opioid receptor antagonists

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194007A (en) * 1978-01-13 1980-03-18 Scott Eugene J Van α-Hydroxyretinoic acid, α-ketoretinoic acid and mixtures and their use in treating skin conditions
US4456618A (en) * 1982-10-15 1984-06-26 Sri International Naphthenic and heterocyclic retinoic acid analogues
US4568757A (en) * 1984-01-30 1986-02-04 Research Triangle Institute Configurationally locked retinoids

Also Published As

Publication number Publication date
NZ239844A (en) 1993-04-28
JP2943089B2 (ja) 1999-08-30
IE66745B1 (en) 1996-02-07
JPH04270261A (ja) 1992-09-25
DK0476682T3 (da) 1995-04-03
PT99014B (pt) 1999-02-26
IE913318A1 (en) 1992-02-25
OA09514A (en) 1992-11-15
AU637756B2 (en) 1993-06-03
FI104168B1 (fi) 1999-11-30
IL99536A0 (en) 1992-08-18
EP0476682A1 (en) 1992-03-25
EP0476682B1 (en) 1995-02-01
ZA917531B (en) 1992-07-29
CA2051766A1 (en) 1992-03-22
GR3014944T3 (en) 1995-05-31
AU8462691A (en) 1992-03-26
FI914405A0 (fi) 1991-09-19
US5141959A (en) 1992-08-25
ATE117979T1 (de) 1995-02-15
MX9101163A (es) 1992-05-04
FI104168B (fi) 1999-11-30
DE69107153D1 (de) 1995-03-16
IL99536A (en) 1995-10-31
ES2067822T3 (es) 1995-04-01
PT99014A (pt) 1992-08-31
DE69107153T2 (de) 1995-05-24

Similar Documents

Publication Publication Date Title
FI914405A0 (fi) Isoprenoidfosfolipas-a2-inhibitorer och dessa innehaollande preparat.
DE69221794D1 (de) 3-benzyliden-1-carbamoyl-2-pyrrolidon-analoga
DE69705480D1 (de) Verwendung von Oestrogenagonisten und -antagonisten zur Herstellung eines Medikaments zur Behandlung von Atherosklerose, unabhängig von Lipidsenkung
PT90623A (pt) Processo para a preparacao de n-heterociclil-4-guanilalquil-benzamidas uteis como inibidores de protease
ATE263771T1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
FI935944A0 (fi) Pyratsolopyrimidin- samt pyrimidinylbisfosfonestrar som anti- inflammatorer
DK1000034T3 (da) Substituerede 6-alkylphenanthridiner
ATE74269T1 (de) Zellproliferationsinhibitor.
SE8600046L (sv) Anvendning av en esterforening som temporer baktericid och produkt innehallande esterforeningen
BR9103665A (pt) Composicao inseticida e processo para a producao de um composto
PT81556B (pt) Processo para a preparacao de agentes anti-fungicos de triazole
FR2422638A1 (fr) Nouveaux derives de 3,3-dichloro-2-azetidinone, utiles notamment comme agents anti-inflammatoires
DE69302087D1 (de) Trazodone alkyl derivate mit zns wirkung
DK0479175T3 (da) Pradimicinderivater
ES8303372A1 (es) Procedimiento para la fabricacion de un compuesto de fenil-5-alquiltiazolidina-4-ona, 2-substituida
ATE222583T1 (de) Derivate substituierter amidinonaphthylester
JPS54122727A (en) Fungicidal, antiseptic, anti-termitic agent
DK0580378T3 (da) Substituerede benzoatderivater
FI840005A0 (fi) Triorganotenn-acetylsalicylat och dessa innehaollande biocida aemnen
GB2021106A (en) Isopropylbenzene derivatives
DK0802900T3 (da) Antiarytmiske (S)-enantiomerer af methansulfonamider